본문 바로가기
KERD
논문KCI 등재

A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea

3

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Background/Aims: To eliminate hepatitis C virus (HCV) infection, improving public knowledge of and access to HCV screening and treatment is essential. The aim of this study was to evaluate the knowledge of and testing rate for HCV and the opinions about the inclusion of the HCV test in the National Health Examination (NHE) among the general population in South Korea. Methods: A telephone interview survey was conducted by an independent research company using a 16 item-questionnaire (demographics, knowledge of HCV, testing and results, need for screening) in May 2019. The sample population consisted of 1,003 adult Korean residents adjusted by age, sex, and area according to the standard Korean population in 2019. Results: Among the 1,003 participants (505 women, mean age of 47.9 years), 56.4% recognized HCV; 44.4% understood that HCV is transmittable, and 56.8% thought that HCV is curable by medication. The recognition rate tended to increase with an increasing level of education. Testing for anti-HCV antibodies was reported by 91 people (9.1%); among them, 10 people (11.0%) reported a positive result, and eight people received treatment. The common reasons for HCV testing were a health check-up (58.5%), a physician’s recommendation (11.0%) and elevated liver enzyme levels (10.7%). The majority of the population (75.1%) agreed with the integration of HCV into the NHE. Conclusions: The level of knowledge of HCV is suboptimal, and the self-reported testing rate for HCV is less than 10%; however, once HCV infection is diagnosed, the treatment rate seems to be high in South Korea. More active campaigns and effective screening are needed.

Abstract

Background/Aims: To eliminate hepatitis C virus (HCV) infection, improving public knowledge of and access to HCV screening and treatment is essential. The aim of this study was to evaluate the knowledge of and testing rate for HCV and the opinions about the inclusion of the HCV test in the National Health Examination (NHE) among the general population in South Korea. Methods: A telephone interview survey was conducted by an independent research company using a 16 item-questionnaire (demographics, knowledge of HCV, testing and results, need for screening) in May 2019. The sample population consisted of 1,003 adult Korean residents adjusted by age, sex, and area according to the standard Korean population in 2019. Results: Among the 1,003 participants (505 women, mean age of 47.9 years), 56.4% recognized HCV; 44.4% understood that HCV is transmittable, and 56.8% thought that HCV is curable by medication. The recognition rate tended to increase with an increasing level of education. Testing for anti-HCV antibodies was reported by 91 people (9.1%); among them, 10 people (11.0%) reported a positive result, and eight people received treatment. The common reasons for HCV testing were a health check-up (58.5%), a physician’s recommendation (11.0%) and elevated liver enzyme levels (10.7%). The majority of the population (75.1%) agreed with the integration of HCV into the NHE. Conclusions: The level of knowledge of HCV is suboptimal, and the self-reported testing rate for HCV is less than 10%; however, once HCV infection is diagnosed, the treatment rate seems to be high in South Korea. More active campaigns and effective screening are needed.

참고문헌 (30)

  1. Lombardi A, "Hepatitis C: is eradication possible?", Liver Int, 39, pp.416~426 (2019)
  2. "Combating hepatitis B and C to reach elimination by 2030: advocacy brief" (2016)[URL]
  3. Falade-Nwulia O, "Oral direct-acting agent therapy for hepatitis C virus infection : a systematic review", Ann Intern Med, 166, pp.637~648 (2017)
  4. Majumdar A, "Systematic review : current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis", Aliment Pharmacol Ther, 43, pp.1276~1292 (2016)
  5. Carrat F, "Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment : a prospective cohort study", Lancet, 393, pp.1453~1464 (2019)
  6. Nahon P, "Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications", Gastroenterology, 152, pp.142~156 (2017)
  7. Calvaruso V, "Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents", Gastroenterology, 155, pp.411~421 (2018)
  8. Ioannou GN, "HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma", J Hepatol, 68, pp.25~32 (2018)
  9. "Global hepatitis report, 2017" (2017)[URL]
  10. "World Hepatitis Day 2018: Global Summary Report" (2019)[URL]
  11. Clagett B, "Comparison of addressbased sampling and random-digit dialing methods for recruiting young men as controls in a case-control study of testicular cancer susceptibility", Am J Epidemiol, 178, pp.1638~1647 (2013)
  12. Gundersen DA, "Assessing the feasibility and sample quality of a national random-digit dialing cellular phone survey of young adults", Am J Epidemiol, 179, pp.39~47 (2014)
  13. "Resident population and household status"[URL]
  14. Kalton G, "Weighting methods", J Off Stat, 19, pp.81~97 (2003)
  15. Kim DY, "A nationwide seroepidemiology of hepatitis C virus infection in South Korea", Liver Int, 33, pp.586~594 (2013)
  16. Jang ES, "The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015", Hepatol Int, 13, pp.599~608 (2019)
  17. Joon Yeul Nam, "Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study", Gut and Liver, 14(2), pp.207~217 (2020), 거트앤리버 소화기연관학회협의회
  18. Kim KA, "Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population", Liver Int, 39, pp.60~69 (2019)
  19. Korean Association for the Study of the Liver, "KASL clinical practice guidelines : management of hepatitis C", Clin Mol Hepatol, 22, pp.76~139 (2016)
  20. Chung YS, "A large healthcare-associated outbreak of hepatitis C virus genotype 1a in a clinic in Korea", J Clin Virol, 106, pp.53~57 (2018)
  21. Kim HS, "Awareness of chronic viral hepatitis in the United States : an update from the National Health and Nutrition Examination Survey", J Viral Hepat, 26, pp.596~602 (2019)
  22. Rajamoorthy Y, "Knowledge and awareness of hepatitis B among households in Malaysia : a community-based cross-sectional survey", BMC Public Health, 19, pp.47~ (2019)
  23. Hang Pham TT, "Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam", PLoS One, 14, pp.e0208154~ (2019)
  24. Wright KB., "Researching internet-based populations: advantages and disadvantages of online survey research, online questionnaire authoring software packages, and web survey services", J Comput Media Commun, 10, pp.JCMC1034~ (2017)
  25. Coffin PO, "Cost-effectiveness and population outcomes of general population screening for hepatitis C", Clin Infect Dis, 54, pp.1259~1271 (2012)
  26. Deuffic-Burban S, "Assessing the costeffectiveness of hepatitis C screening strategies in France", J Hepatol, 69, pp.785~792 (2018)
  27. Lin C, "The disconnect in hepatitis screening : participation rates, awareness of infection status, and treatment-seeking behavior", J Glob Health, 9, pp.010426~ (2019)
  28. Andriulli A, "Declining prevalence and increasing awareness of HCV infection in Italy : a population-based survey in five metropolitan areas", Eur J Intern Med, 53, pp.79~84 (2018)
  29. Yu ML, "Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan", Medicine(Baltimore), 94, pp.e690~ (2015)
  30. Shin A, "Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea", Cancer Epidemiol Biomarkers Prev, 18, pp.1894~1898 (2009)

관련 논문AI추천

Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination SurveyJune Sung Lee, Kyung-Ah Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제5호The Incidence and Care Cascade of the Hepatitis C Virus in KoreaChon Young Eun, Jo Aejeong, Jun Dae Won, Ko Min Jung, Lee Jonghyun, Shin Ho Gyun, Yoon Eileen L.거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제6호Liver Diseases in South Korea: A Pulse Check of the Public’s Knowledge, Awareness, and Behaviors윤진, 김명화, 안상훈, 이혜원, Shikha Singh연세대학교의과대학 · Yonsei Medical Journal2022 · 제63권 제12호Current status of hepatitis C virus infection and countermeasures in South Korea기모란, 김경아, 장은선, 정숙향, 정완교, 최화영한국역학회 · Epidemiology and Health2017 · 제39권 The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment김강모, 심주현, 이한주, 임영석, 최종기, Chung Young-Hwa, Lee Danbi, Park Jina거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제6호Prevalence, Clinical Characteristics, and Treatment Status of Hepatitis C Virus Infection among People Who Use Drugs in South Korea: A Prospective Multicenter StudyBaik Dahye, Choi Gwang Hyeon, Chon Young-Hoon, Jang Eun Sun, Jang Og-Jin, Jeong Sook-Hyang, Jo Sung Nam, Kim Kyung-Ah, Kwon Do Hoon거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제5호

이 간행물의 다른 논문 (18건)